558 related articles for article (PubMed ID: 26424648)
21. [Infectious mononucleosis in practice of otorhinolaryngologist].
Kryukov AI; Bessarab TP; Tsarapkin GY; Tovmasian AS; Kishinevskii AY; Agaev AG
Vestn Otorinolaringol; 2021; 86(4):79-85. PubMed ID: 34499453
[TBL] [Abstract][Full Text] [Related]
22. Mathematical modelling the age dependence of Epstein-Barr virus associated infectious mononucleosis.
Huynh GT; Adler FR
Math Med Biol; 2012 Sep; 29(3):245-61. PubMed ID: 21700566
[TBL] [Abstract][Full Text] [Related]
23. The need and challenges for development of an Epstein-Barr virus vaccine.
Cohen JI; Mocarski ES; Raab-Traub N; Corey L; Nabel GJ
Vaccine; 2013 Apr; 31 Suppl 2(0 2):B194-6. PubMed ID: 23598481
[TBL] [Abstract][Full Text] [Related]
24. [Epstein-Barr virus hepatitis associated with icterus--a case report].
Canović P; Gajović O; Todorović Z; Mijailović Z
Med Pregl; 2006; 59(3-4):179-82. PubMed ID: 17066593
[TBL] [Abstract][Full Text] [Related]
25. Case Report: Splenic Infarction in Infectious Mononucleosis due to Epstein-Barr Virus Infection.
Nishioka H; Hayashi K; Shimizu H
Am J Trop Med Hyg; 2021 Nov; 106(2):623-625. PubMed ID: 34844205
[TBL] [Abstract][Full Text] [Related]
26. Epstein-Barr virus-positive blastoid variant of mantle cell lymphoma in an adult with recurrent infectious mononucleosis-like symptoms: a case report.
Higuchi M; Muta T; Karube KN; Eto T; Yamano Y; Ohshima K
Int J Hematol; 2007 Apr; 85(3):219-22. PubMed ID: 17483058
[TBL] [Abstract][Full Text] [Related]
27. Infectious Mononucleosis: Rapid Evidence Review.
Sylvester JE; Buchanan BK; Silva TW
Am Fam Physician; 2023 Jan; 107(1):71-78. PubMed ID: 36689975
[TBL] [Abstract][Full Text] [Related]
28. Characterization of Epstein-Barr virus (EBV) BZLF1 gene promoter variants and comparison of cellular gene expression profiles in Japanese patients with infectious mononucleosis, chronic active EBV infection, and EBV-associated hemophagocytic lymphohistiocytosis.
Imajoh M; Hashida Y; Murakami M; Maeda A; Sato T; Fujieda M; Wakiguchi H; Daibata M
J Med Virol; 2012 Jun; 84(6):940-6. PubMed ID: 22511310
[TBL] [Abstract][Full Text] [Related]
29. [The role of Epstein-Barr virus infections in human pathology].
Vujosević M; Gvozdenović E
Med Pregl; 1994; 47(11-12):393-7. PubMed ID: 7476696
[TBL] [Abstract][Full Text] [Related]
30. HLA class I polymorphisms are associated with development of infectious mononucleosis upon primary EBV infection.
McAulay KA; Higgins CD; Macsween KF; Lake A; Jarrett RF; Robertson FL; Williams H; Crawford DH
J Clin Invest; 2007 Oct; 117(10):3042-8. PubMed ID: 17909631
[TBL] [Abstract][Full Text] [Related]
31. Quantitative analysis of Epstein-Barr virus (EBV)-specific CD8+ T cells in patients with chronic active EBV infection.
Sugaya N; Kimura H; Hara S; Hoshino Y; Kojima S; Morishima T; Tsurumi T; Kuzushima K
J Infect Dis; 2004 Sep; 190(5):985-8. PubMed ID: 15295706
[TBL] [Abstract][Full Text] [Related]
32. Primary EBV infection induces an expression profile distinct from other viruses but similar to hemophagocytic syndromes.
Dunmire SK; Odumade OA; Porter JL; Reyes-Genere J; Schmeling DO; Bilgic H; Fan D; Baechler EC; Balfour HH; Hogquist KA
PLoS One; 2014; 9(1):e85422. PubMed ID: 24465555
[TBL] [Abstract][Full Text] [Related]
33. Designing an effective vaccine to prevent Epstein-Barr virus-associated diseases: challenges and opportunities.
Dasari V; Bhatt KH; Smith C; Khanna R
Expert Rev Vaccines; 2017 Apr; 16(4):377-390. PubMed ID: 28276306
[TBL] [Abstract][Full Text] [Related]
34. Toward standardization of Epstein-Barr virus DNA load monitoring: unfractionated whole blood as preferred clinical specimen.
Stevens SJ; Pronk I; Middeldorp JM
J Clin Microbiol; 2001 Apr; 39(4):1211-6. PubMed ID: 11283029
[TBL] [Abstract][Full Text] [Related]
35. Recombinant gp350 vaccine for infectious mononucleosis: a phase 2, randomized, double-blind, placebo-controlled trial to evaluate the safety, immunogenicity, and efficacy of an Epstein-Barr virus vaccine in healthy young adults.
Sokal EM; Hoppenbrouwers K; Vandermeulen C; Moutschen M; Léonard P; Moreels A; Haumont M; Bollen A; Smets F; Denis M
J Infect Dis; 2007 Dec; 196(12):1749-53. PubMed ID: 18190254
[TBL] [Abstract][Full Text] [Related]
36. Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.
Niller HH; Wolf H; Minarovits J
Autoimmunity; 2008 May; 41(4):298-328. PubMed ID: 18432410
[TBL] [Abstract][Full Text] [Related]
37. Murine gamma-herpesvirus 68 glycoprotein 150 protects against virus-induced mononucleosis: a model system for gamma-herpesvirus vaccination.
Stewart JP; Micali N; Usherwood EJ; Bonina L; Nash AA
Vaccine; 1999 Jan; 17(2):152-7. PubMed ID: 9987149
[TBL] [Abstract][Full Text] [Related]
38. Hematologic differences in heterophile-positive and heterophile-negative infectious mononucleosis.
Ventura KC; Hudnall SD
Am J Hematol; 2004 Aug; 76(4):315-8. PubMed ID: 15282662
[TBL] [Abstract][Full Text] [Related]
39. Epstein-Barr virus--associated diseases in humans.
Kawa K
Int J Hematol; 2000 Feb; 71(2):108-17. PubMed ID: 10745621
[TBL] [Abstract][Full Text] [Related]
40. Pediatric epstein-barr virus carriers with or without tonsillar enlargement may substantially contribute to spreading of the virus.
Hug M; Dorner M; Fröhlich FZ; Gysin C; Neuhaus D; Nadal D; Berger C
J Infect Dis; 2010 Oct; 202(8):1192-9. PubMed ID: 20815705
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
